TENX
Tenax Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-10
Figures on this page computed 2026-11-08 12:48 UTC
Last close
1.81USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-10
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099393
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-10
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099393
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-07-31
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099393
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099393
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
0.00Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099393
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-07-31
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.10 against 0.46 on the market's range.
- Growth-198.8%10 of 100, below its sector
- Returns on capital-54.2%15 of 100, below its sector
- Marginsn/anot placed
- Price0.7x80 of 100, above its sector
- Safety0.0073 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9Where it sells it
2Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
0 segments, 2 places and 0 named customers, each as the filer published it.
0 segments, 2 places and 0 named customers, each as the filer published it.
Every figure in this lens
Except where said otherwise: 10-K for 2013, filed 2013-06-26
Europe46,667
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2013
- Accession
- 0001354488-13-003629
- Reported in
- USD
United States46,016
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2013
- Accession
- 0001354488-13-003629
- Reported in
- USD